JUMP TO CONTENT

What are the four phases of a clinical trial?

Posting date: 22/05/2022
Author: Inside ICON

Having enjoyed steady growth over the last several years, it’s predicted that the global clinical trials market will hit a value of $65.2 billion by 2025, and around 58% of this can be attributed to research within oncology. This is being driven by an increased demand for Clinical Research Organisations (CROs) to conduct clinical trials, a move towards personalised treatment and digitalisation of the healthcare market.

Despite the notable expansion of the market, it can take up to 15 years to get a new medicine or treatment to market because of the lengthy procedure of obtaining a licence. The process is split into distinct stages and each is thought of as a separate study where researchers are only permitted to move to the next stage once the U.S. Food and Drug Administration (FDA), Medicines and Healthcare Products Regulatory Agency (MHRA), European Medicines Agency (EMA) or other regulatory agency gives their approval. Here are the four phases of a clinical trial.

Phase I

Though there is sometimes a phase 0 to test whether researchers were correct about the way the body reacts to a drug, often clinical trials will start at phase I. A clinical trial refers to a study within clinical research where patients are monitored to determine the efficacy of a treatment; this can be a drug, medical device or procedure. Therefore, from the very first stage, a clinical operations team will be testing to see how the drug is broken down by the body, looking for side effects and beginning to find the optimal dosage.

Phase I ranges between several months to a year and tests the treatment on a small group of healthy patients. Once the trial is complete the drug safety associate (DSA) will submit their research to the regulatory agency at which point the FDA reports that around 7 in 10 receive approval.

Phase II

Those drugs, wearables or other treatments that pass approval at the first stage of clinical trials will progress to phase II where the focus is to test on a larger sample and typically introduce a placebo group. The placebo group - usually a randomised sample - will receive an inactive drug or a dummy treatment which allows clinical research associates (CRAs) to identify whether patients show side effects because they believe they’re receiving the treatment. Researchers can then compare the effectiveness of the treatment against the placebo group to get a clear picture of how well it works.

At this stage, clinical trial assistants (CTAs) are also assessing the safety of the treatment and monitoring any short-term adverse effects and phase II will normally span two years. The FDA reveals that the success rate at this stage is just 33%.

Phase III

At phase III, a clinical trial manager will work alongside the project manager to identify if the drug has an overall positive effect on the patient’s wellbeing. Having qualified to this stage CRO companies will recruit more patients into randomised groups to get a clearer picture of data discrepancies and therefore understand the success of the drug.

Treatments which receive approval after phase III are awarded a licence meaning that the medicine can go to market and be prescribed to the public. Over the last 10 years, US drug manufacturers have spent on average $1 billion getting their drug to market and this is partially due to rising costs associated with advancements in technology.

Read more on why you should be a project manager.

HTML Image as link


Phase IV

The fourth and final stage is tested once the drug has gone to market and is designed to understand the side effects better and establish if there are any long-term risks throughout the life span of the drug. At phase IV DSAs are evaluating the outcomes on a more wide-spread basis – generally in the thousands.

Work on some of the most exciting clinical trials with ICON

At ICON, we’re determined to be the partner of choice in drug development and this ambition sees us working on an extensive variety of projects. For more insight read about the impact of Covid-19 on pharmacovigilance.

Related Content

List #1

Related jobs at ICON

Clinical Trial Manager - Canada Remote

Salary

Location

Canada

Department

Clinical Trial Management

Location

Canada

Remote Working

Home-Based

Business Area

ICON Strategic Solutions

Job Categories

Clinical Trial Management

Job Type

Permanent

Description

As a Clinical Trial Manager you will be joining the world’s largest & most comprehensive clinical research organisation, powered by healthcare intelligence.

Reference

2025-120261

Expiry date

01/01/0001

Brandon Pupek

Author

Brandon Pupek
Read more Shortlist Save this role
Clinical Trial Manager - Canada Remote*

Salary

Location

Canada

Department

Clinical Trial Management

Location

Canada

Remote Working

Home-Based

Business Area

ICON Strategic Solutions

Job Categories

Clinical Trial Management

Job Type

Permanent

Description

As a Clinical Trial Manager you will be joining the world’s largest & most comprehensive clinical research organisation, powered by healthcare intelligence.

Reference

2025-120256

Expiry date

01/01/0001

Brandon Pupek

Author

Brandon Pupek
Read more Shortlist Save this role
Clinical Trial Manager - Canada Remote

Salary

Location

Canada

Department

Clinical Trial Management

Location

Canada

Remote Working

Home-Based

Business Area

ICON Strategic Solutions

Job Categories

Clinical Trial Management

Job Type

Permanent

Description

As a Clinical Trial Manager you will be joining the world’s largest & most comprehensive clinical research organisation, powered by healthcare intelligence.

Reference

2025-120492

Expiry date

01/01/0001

Brandon Pupek

Author

Brandon Pupek
Read more Shortlist Save this role
Clinical Trial Manager II

Salary

Location

US, Blue Bell (ICON)

Location

Blue Bell

Remote Working

Home or Office

Business Area

ICON Full Service & Corporate Support

Job Categories

Clinical Trial Management

Job Type

Permanent

Description

We are currently seeking a Clinical Trial Manager II to join our diverse and dynamic Early Phase team. As a Clinical Trial Manager II within IEB (Early Phase), you will play a pivotal role in designin

Reference

JR132536

Expiry date

01/01/0001

Michael Hartley Read more Shortlist Save this role
View all
List #1

Related stories

Two medics at ICON clinical research clinic
The Strategic Role of Site Selection and Activation in Clinical Trials

Teaser label

Industry

Content type

Blogs

Publish date

07/07/2025

Summary

Precision at the Outset: The Strategic Role of Site Selection and Activation in Clinical Trials The success of any clinical trial begins well before the first patient is enrolled. Behind every sit

Teaser label

Explore the critical role of site selection and activation in clinical trials.

Read more
3 x Digital padlocks
The Role of Cybersecurity in Clinical Data Management

Teaser label

Industry

Content type

Blogs

Publish date

07/04/2025

Summary

Cybersecurity in Clinical Data Management In clinical research, data is both a vital asset and a significant responsibility. As trials become increasingly digitised and decentralised, the protectio

Teaser label

Learn about the critical role cybersecurity plays in an increasingly digital research environment.

Read more
Stethoscope on paper
Specialisations in Clinical Research: Finding Your Niche

Teaser label

Industry

Content type

Blogs

Publish date

07/03/2025

Summary

Finding the Specialisation for You Clinical research is a dynamic, multidisciplinary field that brings together scientific innovation, operational rigour and patient-centric thinking. While many

Teaser label

Explore the diverse specialisations in clinical research, from clinical operations to data management, regulatory affairs, and beyond.

Read more
View all
List #1

Recently viewed jobs

Senior Biostatistician II

Salary

Location

UK, Swansea

Location

Sofia

Dublin

Warsaw

Lisbon

Belgrade

Johannesburg

Madrid

Swansea

Remote Working

Home or Office

Business Area

ICON Full Service & Corporate Support

Job Categories

Biostatistician

Job Type

Permanent

Description

We are currently seeking a Senior Biostatistician I to join our diverse and dynamic team. As a Senior Biostatistician I at ICON, you will play a pivotal role in designing and analyzing clinical trials

Reference

JR128830

Expiry date

06/09/2026

Rowena Deswert Read more Shortlist Save this role
View all
View Jobs

Browse popular job categories below or search all jobs above